2017 Meeting Report: The American Urological Association’s (AUA) Annual Meeting


At the 2017 American Urological Association meeting held in Boston, focused ultrasound technology was included in 15 abstracts, and EDAP released its new Ablatherm “Fusion” technology, which allows urologists to import pre-treatment diagnostic information (MRI images and 3D biopsy maps) and merge it with the live ultrasound image during the procedure.

AUA Abstracts

AUA2017 logoThe full text for each abstract can be found online in the Journal of Urology, Volume 197 Issue 4.

MP08-17 Is Magnetic Resonance Imaging Sensitive Enough for Partial Gland High Intensity Focused Ultrasound Treatment? Comparing Prostate Cancer Lesions between Magnetic Resonance Imaging and Prostatectomy Specimens. Bahler et al. e98

MP24-14 No Stoma, One, Or Two? Setting Expectations For Patients with Rectourethral Fistula. Chi et al. e307

MP47-07 Salvage Robotic-Assisted Radical Prostatectomy: Oncologic and Functional Outcomes from Two High-volume Institutions. Ogaya-Pinies et al. e630 – e631

MP64-02 Oncological Outcomes of Salvage Radical Prostatectomy: A Multicentre Series of 243 Patients. Marra et al. e844 – e845

MP70-09 Predictors of Biochemical Recurrence after Primary Focal Cryotherapy for Localized Prostate Cancer: A Multi-Institutional Analytic Comparison of the Phoenix and Stuttgart Criteria. Kongnyuy et al. e938

MP70-10 New Approach to Focal Therapy of Localized Prostate Cancer With “Fusion” Integrated Path and High Intensity Focused Ultrasound (HIFU): Initial Experience. Branchi et al. e938 – e939

MP70-11 Medium Term Outcomes Following Focal HIFU for the Treatment of Localised Prostate Cancer: A Single Centre Experience. Mistry et al. e939

MP70-14 PSA Nadir and PSA Flare are the Predictors of Biochemical Failure after High-Intensity Focused Ultrasound Treatment of Localized Prostate Cancer. Ibuki et al. e940

MP70-16 Safety and Feasibility of Real-Time MRI-guided Focused Ultrasound for Focal Therapy of Localized Prostate Cancer Using the Exablate 2100 Device: Phase 1 Study. Perlis et al. e941

MP93-02 Comparison of Oncological Outcomes Between Open Versus Robot-Assisted Salvage Radical Prostatectomy: A Retrospective Multicentre Series. Gontero et al. e1236

MP100-02 Boiling Histotripsy Ablation of Renal Carcinoma in a Chronic Rat Model. Brisbane et al. e1329 – e1330

MP100-14 High Intensity Focused Ultrasound Kidney Ablation: Pre-Clinical Safety and Efficacy Evaluation in a Porcine Model Using a 15mm Laparoscopic Probe. Chopra et al. e1335 – e1336

PD56-08 The PART Trial – A Phase III Study Comparing Partial Prostate Ablation Versus Radical Prostatectomy (PART) in Intermediate Risk Prostate Cancer – Early Data from the Feasibility Study. Leslie et al. e1118 – e1119

PD56-10 Urologist’s Practice Patterns and Preferences Regarding Focal Therapy for Prostate Cancer. Jain et al. e1119 – e1120

V4-07 Contrast-Enhanced Ultrasound (CEUS): Evaluation of High Intensity Focused Ultrasound (HIFU) Ablation of the Prostate. Abreu et al. e377 – e378